Vote Scores
Filings read through

Janux Therapeutics, Inc.: how funds voted at the meeting of 11 Jun 2026

Ticker
JANX
Meeting
Season
year to 30 June 2026
Filers reporting
299
Ballot items
3

299 filers on Form N-PX reported votes at the Janux Therapeutics, Inc. meeting of 11 Jun 2026. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 79.9% of the reported votes are for. 42 filers withheld from or voted against at least one nominee.

    366 vote records from 96 filers. 3 of the 96 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 21
    • Abstain or withhold 2
    • Split or no vote 14
    • Against management 2
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    435 vote records from 298 filers. 78 of the 281 filers that marked the item voted against management. 17 filers gave no management mark.

    • Positions of 43 fund families
    • For 30
    • Against 13
    • Against management 13
  3. Item 3: Audit-related items (auditor ratification)

    183 vote records from 96 filers. 1 of the 96 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 37

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Janux Therapeutics, Inc., meeting of 11 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForNo report
AllspringForFor
American CenturyAgainst, against managementFor
BlackRock and iSharesForFor
BNY MellonForNo report
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForFor
DimensionalAgainst, against managementFor
DWSForFor
EquitableForFor
Federated HermesAgainst, against managementFor
FidelityForFor
First TrustForNo report
Franklin TempletonForFor
Global XAgainst, against managementFor
Goldman SachsForFor
Guggenheim and RydexForFor
Hartford FundsAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonForFor
John Hancock and ManulifeForFor
Lincoln FinancialForFor
Macquarie and Delaware FundsForFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementNo report
Neuberger BermanAgainst, against managementNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialAgainst, against managementFor
PrincipalForFor
ProShares and ProFundsForFor
Russell InvestmentsAgainst, against managementNo report
SEIAgainst, against managementFor
State Street and SPDRForFor
T. Rowe PriceForFor
VanguardForFor
Victory CapitalForFor
VoyaForFor

Questions

How many filers reported votes at the Janux Therapeutics, Inc. meeting?
299 Form N-PX filers reported votes at the meeting of 11 Jun 2026. On say-on-pay, 78 of 281 filers that marked the item voted against management (27.8%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Janux Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Janux Therapeutics, Inc. with a meeting date within three days of 11 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .